Research map: A Bayesian Optimal Adaptive Clinical Trial Design for Sequentially Integrated Therapies

Back to the article

Papers in this map

  1. A Model to Predict Survival in Patients With End–Stage Liver Disease · Patrick S. Kamath · 2001 · 5009 citations · Cited by this paper
  2. Choosing Covariate Balancing Methods for Causal Inference: Practical Insights From a Simulation Study · 2026 · Related
  3. Interval Estimation for a Binomial Proportion · Lawrence D. Brown · 2001 · 3622 citations · Cited by this paper
  4. A Bayesian Learning Model for Joint Risk Prediction of Alcohol and Cannabis Use Disorders · 2026 · Related
  5. Alcoholic liver disease · Helmut K. Seitz · 2018 · 1207 citations · Cited by this paper
  6. Identifiable Copula‐Double‐Cox Models: A Fully Parametric Framework for Dependent Right‐Censored Survival Data · 2026 · Related
  7. Alcoholic Liver Disease · Robert S. O’Shea · 2009 · 1078 citations · Cited by this paper
  8. Covariate Adjustment for Wilcoxon Two Sample Statistic and Test · 2026 · Related
  9. MELD and PELD: Application of survival models to liver allocation · Russell H. Wiesner · 2001 · 877 citations · Cited by this paper
  10. Semiparametric Panel Count Model, With Applications to Signal Detection in Post‐Market Drug Surveillance Systems · 2026 · Related
  11. ACG Clinical Guideline: Alcoholic Liver Disease · Ashwani Kumar Singal · 2018 · 852 citations · Cited by this paper
  12. Cluster Trials Inference With CARE · 2026 · Related
  13. Prednisolone or Pentoxifylline for Alcoholic Hepatitis · Mark R. Thursz · 2015 · 770 citations · Cited by this paper
  14. Efficiency Enhancement in Testing Treatment Efficacy Across Multiple Populations Using Treatment Crossover Data · 2026 · Related
  15. An experimental design for the development of adaptive treatment strategies · Susan A. Murphy · 2004 · 751 citations · Cited by this paper
  16. Fast Estimation and Valid Statistical Inference for Mixed‐Effect Location‐Scale Models Using Variational Inference · 2026 · Related
  17. Rates and predictors of relapse after natural and treated remission from alcohol use disorders · Rudolf H. Moos · 2006 · 610 citations · Cited by this paper
  18. Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta‐Diversity · 2026 · Related
  19. Statistical Methods for Dynamic Treatment Regimes · Bibhas Chakraborty · 2013 · 347 citations · Cited by this paper
  20. Inverse‐Intensity‐Weighted Generalized Estimating Equations With Irregularly Measured Longitudinal Data and Informative Dropout · 2026 · Related
  21. Motivational interviewing, enhancement, and brief interventions over the last decade: A review of reviews of efficacy and effectiveness. · Carlo C. DiClemente · 2017 · 301 citations · Cited by this paper
  22. Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders · Lara A. Ray · 2020 · 267 citations · Cited by this paper
  23. Alcohol-Associated Hepatitis · Ramon A. Bataller · 2022 · 252 citations · Cited by this paper
  24. Practical Bayesian Guidelines for Phase IIB Clinical Trials · Peter F. Thall · 1994 · 249 citations · Cited by this paper
  25. Bayesian clinical trials in action · J. Jack Lee · 2012 · 217 citations · Cited by this paper
  26. Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: A prospective study · Alexandre Louvet · 2017 · 215 citations · Cited by this paper
  27. A Simple Score for Predicting Alcohol Relapse After Liver Transplantation · Andrea De Gottardi · 2007 · 213 citations · Cited by this paper
  28. Two-stage selection and testing designs for comparative clinical trials · Peter F. Thall · 1988 · 209 citations · Cited by this paper
  29. Prednisolone With vs Without Pentoxifylline and Survival of Patients With Severe Alcoholic Hepatitis · Philippe Mathurin · 2013 · 209 citations · Cited by this paper
  30. Evaluating multiple treatment courses in clinical trials · Peter F. Thall · 2000 · 138 citations · Cited by this paper
  31. Seamlessly Expanding a Randomized Phase II Trial to Phase III · Lurdes Y. T. Inoue · 2002 · 134 citations · Cited by this paper
  32. BOP2: Bayesian optimal design for phase II clinical trials with simple and complex endpoints · Heng Zhou · 2017 · 132 citations · Cited by this paper
  33. Optimal design of multi‐arm multi‐stage trials · James M. S. Wason · 2012 · 129 citations · Cited by this paper
  34. IL‐1 receptor antagonist plus pentoxifylline and zinc for severe alcohol‐associated hepatitis · Gyöngyi Szabó · 2022 · 103 citations · Cited by this paper
  35. CDC Sexually Transmitted Infections Treatment Guidelines, 2021 · Aniruddha Hazra · 2022 · 95 citations · Cited by this paper
  36. Bayesian interim analysis of phase II cancer clinical trials · Daniel F. Heitjan · 1997 · 94 citations · Cited by this paper
  37. Gabapentin Enacarbil Extended‐Release for Alcohol Use Disorder: A Randomized, Double‐Blind, Placebo‐Controlled, Multisite Trial Assessing Efficacy and Safety · Daniel E. Falk · 2018 · 87 citations · Cited by this paper
  38. Phase II Trial Design with Bayesian Adaptive Randomization and Predictive Probability · Guosheng Yin · 2012 · 83 citations · Cited by this paper
  39. Alcohol-Associated Liver Disease: Integrated Management With Alcohol Use Disorder · Juan Pablo Arab · 2023 · 72 citations · Cited by this paper

Source: OpenAlex (CC0)